Related references
Note: Only part of the references are listed.High-mobility group box-1 in ischemia-reperfusion injury of the heart
Martin Andrassy et al.
CIRCULATION (2008)
sRAGE is elevated in septic patients and associated with patients outcome
Christian Bopp et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium
Ke Zen et al.
JOURNAL OF IMMUNOLOGY (2007)
Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection
Emily C. Lutterloh et al.
CRITICAL CARE (2007)
Posttranslationally modified proteins as mediators of sustained intestinal inflammation
Martin Andrassy et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Sepsis-induced cholestasis, steatosis, hepatocellular injury, and impaired hepatocellular regeneration are enhanced in interleukin-6-/- mice
Clifford S. Deutschman et al.
CRITICAL CARE MEDICINE (2006)
Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27
Stefan Wirtz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products
Vedat Schwenger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Understanding RAGE, the receptor for advanced glycation end products
A Bierhaus et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Heterogeneity and oxidation status of commercial human albumin preparations in clinical use
D Bar-Or et al.
CRITICAL CARE MEDICINE (2005)
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
B Liliensiek et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment
T Chavakis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes - The EURODIAB prospective complications study
MT Schram et al.
DIABETES CARE (2003)
Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy
ME Suliman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Central role of RAGE-dependent neointimal expansion in arterial restenosis
T Sakaguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Glycation by ascorbic acid causes loss of activity of ribulose-1,5-bisphosphate carboxylase/oxygenase and its increased susceptibility to proteases
Y Yamauchi et al.
PLANT AND CELL PHYSIOLOGY (2002)
AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression
E Boulanger et al.
KIDNEY INTERNATIONAL (2002)
Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation
K Sebekova et al.
JOURNAL OF HEPATOLOGY (2002)
Diabetes-associated sustained activation of the transcription factor nuclear factor-κB
A Bierhaus et al.
DIABETES (2001)
Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy
HIA Sati et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line
R Constien et al.
GENESIS (2001)
Effect of collagen turnover on the accumulation of advanced glycation end products
N Verzijl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Mechanisms for the formation of glycoxidation products in end-stage renal disease
MF Weiss et al.
KIDNEY INTERNATIONAL (2000)
Endothelin 1 transcription is controlled by nuclear factor-kappa B in AGE-stimulated cultured endothelial cells
P Quehenberger et al.
DIABETES (2000)
Share Paper
